Negotiating Drug Prices: The Debate Continues
With the House passing legislation giving the government the ability to negotiate drug prices for people on Medicare, rhetoric is heating up and data is flying from people on both sides of the debate.
Pro Price Negotiations: Joe Paduda has this analysis of statistics used by opponents of the House plan. He says that some are “using faulty methodology and selective data to promote a perspective.â€
Against Price Negotiations: Pfizer produced this video that highlights its arguments against price negotiations and says that they would lead to less innovation in critical areas, including Alzheimer’s.
